HealthcareVor Bio stock rallies post-market on trem-cel study dataBy Helitra.com·September 6, 2024·1 min read Vor Bio stock rallies post-market on trem-cel study data Source: SeekingalphaADVERTISEMENT ADVERTISEMENTBio data postmarket rallies stock study tremcel Vor Post navigation Previous storyaTyr started at buy by Jefferies, citing efzofitimod potentialNext storyAscendis raised to outperform by Oppenheimer ahead of drug launch
Fitness · HealthcareHow Kids’ Brains Reacted to Photos of Cookies and Fries Was Linked to Later Weight GainNovember 5, 2026The kids in the MRI scanner saw pictures of cookies and fries. Those who ate more ultra-processed foods in their usual diets showed…
Fitness · HealthcareShould you sleep with socks on? Doctors weigh inNovember 5, 2026You know those people who are always cold? That’s me. So it should come as no surprise that I wear socks (and Crocs!)…
Fitness · HealthcareExercise Lowers Dementia Risk—But There’s a Surprising Catch, Study FindsNovember 5, 2026For years, experts have emphasized the importance of exercise and physical activity in reducing dementia risk—and for good reason. Research shows that people…